AIDS Healthcare Foundation (AHF) will hold an in-person and virtual press conference at the AHF booth (#111) during the 2024 International AIDS Conference (AIDS 2024) on Tuesday, July 23, at 13:15 CEST (7:15 a.m. US EDT) in Munich, Germany, at the Messe München Convention Center, and virtually via Zoom. Public health advocates and experts will emphasize how global access to affordable medicines is being hindered by the profit-driven strategies of Gilead Sciences and other major pharmaceutical companies. The relentless pursuit of profit leaves millions in low- and middle-income countries without access to lifesaving medicines.
“Gilead has harmed people living with HIV worldwide for over two decades by securing continual patents, known as ‘evergreening,’ and generating billions through monopolies on effective and well-tolerated antiretroviral HIV drugs,” said Terri Ford, AHF Chief of Global Advocacy & Policy. “AIDS 2024 is the perfect platform to demand Gilead prioritize lives over its greedy tactics that limit access to essential medicines.”
As a leading global HIV/AIDS organization with over 2 million patients in 47 countries, AHF calls on governments and decision-makers to exert pressure on Gilead to prioritize lives over excessive profits.
Advocates will also stress that HIV/AIDS remains a significant global public health crisis, causing 630,000 deaths annually. According to UNAIDS, over 39 million people were living with HIV in 2022, including 1.3 million new cases. Since the pandemic began, more than 40 million people have died from AIDS-related illnesses.
AIDS Healthcare Foundation (AHF) is a global non-profit organization providing cutting-edge medicine and advocacy to over 2 million people in 47 countries across Africa, the Americas, the Asia/Pacific Region, and Europe. We are the largest non-profit provider of HIV/AIDS medical care worldwide.
